244 related articles for article (PubMed ID: 11030069)
1. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
2. Clinical and electrophysiological studies in vincristine induced neuropathy.
Pal PK
Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
[TBL] [Abstract][Full Text] [Related]
3. Vincristine neurotoxicity in the presence of hereditary neuropathy.
Trobaugh-Lotrario AD; Smith AA; Odom LF
Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
[No Abstract] [Full Text] [Related]
4. Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia.
Brigo F; Balter R; Marradi P; Ferlisi M; Zaccaron A; Fiaschi A; Frasson E; Bertolasi L
J Child Neurol; 2012 Jul; 27(7):867-74. PubMed ID: 22241706
[TBL] [Abstract][Full Text] [Related]
5. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
6. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine.
Hartman A; van den Bos C; Stijnen T; Pieters R
Cancer; 2006 Mar; 106(6):1395-401. PubMed ID: 16453332
[TBL] [Abstract][Full Text] [Related]
7. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
Mokhtar GM; Shaaban SY; Elbarbary NS; Fayed WA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):594-600. PubMed ID: 20921909
[TBL] [Abstract][Full Text] [Related]
8. Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.
Jain P; Gulati S; Seth R; Bakhshi S; Toteja GS; Pandey RM
J Child Neurol; 2014 Jul; 29(7):932-7. PubMed ID: 23781018
[TBL] [Abstract][Full Text] [Related]
9. Nerve lesions after therapy for childhood acute lymphoblastic leukemia.
Harila-Saari AH; Vainionpää LK; Kovala TT; Tolonen EU; Lanning BM
Cancer; 1998 Jan; 82(1):200-7. PubMed ID: 9428498
[TBL] [Abstract][Full Text] [Related]
10. [Electroneurophysiological and clinical consequences of therapy of acute lymphoblastic leukemia in children].
Kroczka S; Kaciński M; Skoczeń S; Balwierz W
Przegl Lek; 2003; 60 Suppl 1():48-53. PubMed ID: 12945163
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiological studies in vincristin-polyneuropathy (author's transl)].
Mamoli B; Heiss WD; Podreka I; Turnheim M
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1980 Mar; 11(1):21-7. PubMed ID: 6773738
[TBL] [Abstract][Full Text] [Related]
12. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
13. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
14. Vincristine-induced vocal cord palsy: case report and review of the literature.
Latiff ZA; Kamal NA; Jahendran J; Alias H; Goh BS; Syed Zakaria SZ; Jamal R
J Pediatr Hematol Oncol; 2010 Jul; 32(5):407-10. PubMed ID: 20505534
[TBL] [Abstract][Full Text] [Related]
15. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
16. Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.
Frost BM; Lönnerholm G; Koopmans P; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Uges DR; de Graaf SS
Acta Paediatr; 2003 May; 92(5):551-7. PubMed ID: 12839283
[TBL] [Abstract][Full Text] [Related]
17. Bilateral vocal cord paralysis following treatment with vincristine.
Naithani R; Dolai TK; Kumar R
Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
[TBL] [Abstract][Full Text] [Related]
18. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
19. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.
Harila-Saari AH; Huuskonen UE; Tolonen U; Vainionpää LK; Lanning BM
Med Pediatr Oncol; 2001 Mar; 36(3):345-51. PubMed ID: 11241435
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
Jeng MR; Feusner J
Pediatr Hematol Oncol; 2001 Mar; 18(2):137-42. PubMed ID: 11255732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
